The Asia-Pacific drug delivery devices market is expected to reach USD 669.66 billion by 2031 from USD 320.82 billion in 2023, growing at a CAGR of 9.9% in the forecast period of 2024 to 2031.
Asia-Pacific Drug Delivery Devices Market, By Product Type (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ophthalmic Drug Delivery, Nasal Drug Delivery, Pulmonary Drug Delivery, Transmucosal Drug Delivery, and Implantable Drug Delivery), End User (Hospitals, Home Healthcare, Clinics, Community Healthcare, and Others), Distribution Channel (Direct Tenders, Hospital Pharmacies, Pharmacy Stores, and Online Pharmacy), Country (Japan, China, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines, Australia, and rest of Asia-Pacific) - Industry Trends and Forecast to 2031 Overview of Asia-Pacific Drug Delivery Devices Market Dynamics: Driver • Rising prevalence of chronic disease and non-chronic disease Restraint • High costs of injectable drugs Opportunity • Rising acceptance of self-administering drug devices Market Players: The key market players operating in the Asia-Pacific drug delivery devices market are listed below: • Johnson & Johnson Services, Inc. • Novartis AG • F.Hoffmann-La Roche Ltd • Bayer AG • Pfizer Inc. • 3M • AbbVie Inc. • Amgen Inc. • BD • Elcam Medical • Gerresheimer AG • GSK plc. • Insulet Corporation • Medmix • Merck & Co., Inc. • OraSure Technologies Inc. • Sanofi • SMC Ltd. • West Pharmaceutical Services Inc.
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Asia-pacific Drug Delivery Devices Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Market End User Coverage Grid
2.8 Product Type Lifeline Curve
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Porters Five Forces
4.2 Pestel Analysis
5 Regulatory Framework
6 Market Overview
6.1 Drivers
6.1.1 Rising Prevalence Of Chronic Disease And Non-chronic Disease
6.1.2 Growth In The Development Of Biologics Drugs Devices
6.1.3 Increasing Awareness About Diagnosis And Treatment
6.1.4 Increased Focus On Personalized Medicine And Devices
6.2 Restraints
6.2.1 Risk Of Needle-stick Injuries And Side Effects
6.2.2 High Costs Of Injectable Drugs
6.2.3 Stringent Regulatory Scenario
6.3 Opportunities
6.3.1 Rising Acceptance Of Self-administering Drug Devices
6.3.2 Rising Demand For Biosimilar And Generic Drugs
6.3.3 Therapeutic Advancements In The Field Of Drug Delivery
6.4 Challenges
6.4.1 Side Effects Of Drug Delivery Systems
6.4.2 Increase In The Number Of Alternatives Of Drug Delivery
7 Asia-pacific Drug Delivery Devices Market, By Product Type
7.1 Overview
7.2 Oral Drug Delivery
7.2.1 Solid Oral Drugs
7.2.1.1 Tablets
7.2.1.2 Capsules
7.2.1.3 Pills
7.2.1.4 Powders
7.2.2 Liquid Oral Drugs
7.2.2.1 Syrups
7.2.2.2 Solutions
7.2.3 Semi Solid Oral Drugs
7.2.3.1 Gels
7.2.3.2 Emulsions
7.2.3.3 Elixirs
7.3 Injectable Drug Delivery
7.3.1 Injectable Drug Delivery Formulations
7.3.1.1 Conventional Drug Delivery Formulations
7.3.1.2 Novel Drug Delivery Formulations
7.3.1.3 Long Acting Injection Formulations
7.3.2 Injectable Drug Delivery Devices
7.3.2.1 Conventional Injectable Drug Delivery Devices
7.3.2.1.1 By Material
7.3.2.1.1.1 Glass
7.3.2.1.1.2 Plastic
7.3.2.1.2 By Product Type
7.3.2.1.2.1 Fillable
7.3.2.1.2.2 Pre-filled
7.3.2.1.3 By Usability
7.3.2.1.3.1 Reusable Syringes
7.3.2.1.3.2 Disposable Syringes
7.3.2.2 Self Injection Drug Delivery Devices
7.3.2.2.1 Needle Free Injectors
7.3.2.2.2 Wearable Injectors
7.3.2.2.3 Pen Injector
7.3.2.2.4 Auto Injectors
7.3.2.2.5 Others
7.4 Topical Drug Delivery
7.4.1 Transdermal Drug Delivery Formulations
7.4.1.1 Semi-solid Topical Drug Delivery Formulations
7.4.1.1.1 Ointments
7.4.1.1.2 Creams
7.4.1.1.3 Lotions
7.4.1.1.4 Gels
7.4.1.1.5 Pastes
7.4.1.2 Liquid Topical Drug Delivery Formulations
7.4.1.2.1 Suspensions
7.4.1.2.2 Solutions
7.4.1.3 Solid Topical Drug Delivery Formulations
7.4.1.3.1 Powder
7.4.1.3.2 Suppositors
7.5 Ophthalmic Drug Delivery
7.5.1 Occular Drug Delivery Formulations
7.5.1.1 Liquid Occular Drug Delivery Formulations
7.5.1.1.1 Solutions
7.5.1.1.2 Suspensions
7.5.1.2 Semi Solid Occular Drug Delivery Formulations
7.5.1.2.1 Gels
7.5.1.2.2 Ointments
7.5.2 Occular Drug Delivery Devices
7.6 Nasal Drug Delivery
7.6.1 Nasal Drops
7.6.2 Nasal Sprays
7.6.3 Nasal Powders
7.6.4 Nasal Gels
7.7 Pulmonary Drug Delivery
7.7.1 Metered Dose Inhalers (Mdi)
7.7.2 Dry Powder Inhalers (Dpi)
7.7.3 Nebulizers
7.7.3.1 Jet Nebulizers
7.7.3.2 Ultrasonic Nebulizers
7.7.3.3 Soft Mist Nebulizers
7.8 Transmucosal Drug Delivery
7.8.1 Oral Transmucosal Drug Delivery
7.8.1.1 Buccal Drug Delivery
7.8.1.2 Sublingual Drug Delivery
7.8.2 Other Transmucosal Drug Delivery
7.8.2.1 Rectal Transmucosal Drug Delivery
7.8.2.2 Vaginal Transmucosal Drug Delivery
7.9 Implantable Drug Delivery
7.9.1 Passive Implantable Drug Delivery Devices
7.9.2 Active Implantable Drug Delivery Devices
8 Asia-pacific Drug Delivery Devices Market, By End User
8.1 Overview
8.2 Hospitals
8.3 Home Healthcare
8.4 Clinics
8.5 Community Healthcare
8.6 Others
9 Asia-pacific Drug Delivery Devices Market, By Distribution Channel
9.1 Overview
9.2 Direct Tenders
9.3 Hospital Pharmacies
9.4 Pharmacy Stores
9.5 Online Pharmacy
10 Asia-pacific Drug Delivery Devices Market, By Region
10.1 Asia-pacific
10.1.1 Japan
10.1.2 China
10.1.3 India
10.1.4 South Korea
10.1.5 Australia
10.1.6 Thailand
10.1.7 Malaysia
10.1.8 Singapore
10.1.9 Indonesia
10.1.10 Philippines
10.1.11 Rest Of Asia-pacific
11 Asia-pacific Drug Delivery Devices Market: Company Landscape
11.1 Company Share Analysis: Asia-pacific
12 Swot Analysis
13 Company Profile
13.1 Johnson & Johnson Services, Inc.
13.1.1 Company Snapshot
13.1.2 Revenue Analysis
13.1.3 Company Share Analysis
13.1.4 Product Portfolio
13.1.5 Recent Developments
13.2 Novartis Ag
13.2.1 Company Snapshot
13.2.2 Revenue Analysis
13.2.3 Company Share Analysis
13.2.4 Product Portfolio
13.2.5 Recent Developments
13.3 F. Hoffmann-la Roche Ltd
13.3.1 Company Snapshot
13.3.2 Revenue Analysis
13.3.3 Company Share Analysis
13.3.4 Product Portfolio
13.3.5 Recent Development
13.4 Bayer Ag
13.4.1 Company Snapshot
13.4.2 Revenue Analysis
13.4.3 Company Share Analysis
13.4.4 Product Portfolio
13.5 Pfizer Inc.
13.5.1 Company Snapshot
13.5.2 Revenue Analysis
13.5.3 Company Share Analysis
13.5.4 Product Portfolio
13.5.5 Recent Development
13.6 3m
13.6.1 Company Snapshot
13.6.2 Revenue Analysis
13.6.3 Product Portfolio
13.6.4 Recent Developments
13.7 Abbvie Inc.
13.7.1 Company Snapshot
13.7.2 Revenue Analysis
13.7.3 Product Portfolio
13.7.4 Recent Developments
13.8 Amgen Inc.
13.8.1 Company Snapshot
13.8.2 Revenue Analysis
13.8.3 Product Portfolio
13.8.4 Recent Developments
13.9 Bd
13.9.1 Company Snapshot
13.9.2 Revenue Analysis
13.9.3 Product Portfolio
13.9.4 Recent Development
13.10 Elcam Medical
13.10.1 Company Snapshot
13.10.2 Product Portfolio
13.10.3 Recent Development
13.11 Enable Injections
13.11.1 Company Snapshot
13.11.2 Product Portfolio
13.11.3 Recent Developments
13.12 Gerresheimer Ag
13.12.1 Company Snapshot
13.12.2 Revenue Analysis
13.12.3 Product Portfolio
13.12.4 Recent Developments
13.13 Gsk Plc.
13.13.1 Company Snapshot
13.13.2 Revenue Analysis
13.13.3 Product Portfolio
13.13.4 Recent Developments
13.14 Insulet Corporation
13.14.1 Company Snapshot
13.14.2 Revenue Analysis
13.14.3 Product Portfolio
13.14.4 Recent Developments
13.15 Medmix
13.15.1 Company Snapshot
13.15.2 Revenue Analysis
13.15.3 Product Portfolio
13.15.4 Recent Developments
13.16 Merck & Co., Inc.
13.16.1 Company Snapshot
13.16.2 Revenue Analysis
13.16.3 Product Portfolio
13.16.4 Recent Development
13.17 Orasure Technologies Inc.
13.17.1 Company Snapshot
13.17.2 Revenue Analysis
13.17.3 Product Portfolio
13.17.4 Recent Development
13.18 Sanofi
13.18.1 Company Snapshot
13.18.2 Revenue Analysis
13.18.3 Product Portfolio
13.18.4 Recent Developments
13.19 Smc Ltd.
13.19.1 Company Snapshot
13.19.2 Revenue Analysis
13.19.3 Product Portfolio
13.19.4 Recent Developments
13.20 Vivo Smart Medical Devices Ltd.
13.20.1 Company Snapshot
13.20.2 Product Portfolio
13.20.3 Recent Development
13.21 West Pharmaceutical Services, Inc.
13.21.1 Company Snapshot
13.21.2 Revenue Analysis
13.21.3 Product Portfolio
13.21.4 Recent Development
14 Questionnaire
15 Related Reports
Table 1 List Of Fda Approved Biologics, In 2022
Table 2 10 Most Expensive Drugs In The U.S. (In Usd Million)
Table 3 Asia-pacific Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 4 Asia-pacific Oral Drug Delivery In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 5 Asia-pacific Oral Drug Delivery In Drug Delivery Devices Market, By Form, 2022-2031 (Usd Million)
Table 6 Asia-pacific Solid Oral Drugs In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 7 Asia-pacific Liquid Oral Drug In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 8 Asia-pacific Semi Solid Oral Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 9 Asia-pacific Injectable Drug Delivery In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 10 Asia-pacific Injectable Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 11 Asia-pacific Injectable Drug Delivery Formulations In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 12 Asia-pacific Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 13 Asia-pacific Conventional Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Material, 2022-2031 (Usd Million)
Table 14 Asia-pacific Conventional Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Product Type 2022-2031 (Usd Million)
Table 15 Asia-pacific Conventional Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Usability, 2022-2031 (Usd Million)
Table 16 Asia-pacific Self Injection Drug Delivery Devices In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 17 Asia-pacific Topical Drug Delivery In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 18 Asia-pacific Topical Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 19 Asia-pacific Transdermal Drug Delivery Formulations In Drug Delivery Devices Market, By Form, 2022-2031 (Usd Million)
Table 20 Asia-pacific Semi-solid Topical Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 21 Asia-pacific Liquid Topical Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 22 Asia-pacific Solid Topical Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 23 Asia-pacific Ophthalmic Drug Delivery In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 24 Asia-pacific Ophthalmic Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 25 Asia-pacific Occular Drug Delivery Formulations In Drug Delivery Devices Market, By Form, 2022-2031 (Usd Million)
Table 26 Asia-pacific Liquid Occular Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 27 Asia-pacific Semi Solid Occular Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 28 Asia-pacific Nasal Drug Delivery In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 29 Asia-pacific Nasal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 30 Asia-pacific Pulmonary Drug Delivery In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 31 Asia-pacific Transmucosal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 32 Asia-pacific Nebulizers In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 33 Asia-pacific Transmucosal Drug Delivery In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 34 Asia-pacific Transmucosal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 35 Asia-pacific Oral Transmucosal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 36 Asia-pacific Other Transmucosal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 37 Asia-pacific Implantable Drug Delivery In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 38 Asia-pacific Topical Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 39 Asia-pacific Drug Delivery Devices Market, By End User, 2022-2031 (Usd Million)
Table 40 Asia-pacific Hospitals In Drug Delivery Market, By Region, 2022-2031 (Usd Million)
Table 41 Asia-pacific Home Healthcare In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 42 Asia-pacific Clinics In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 43 Asia-pacific Community Healthcare In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 44 Asia-pacific Others In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 45 Asia-pacific Drug Delivery Devices Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 46 Asia-pacific Direct Tenders In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 47 Asia-pacific Hospital Pharmacies In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 48 Asia-pacific Pharmacy Stores In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 49 Asia-pacific Online Pharmacy In Drug Delivery Devices Market, By Region, 2022-2031 (Usd Million)
Table 50 Asia-pacific Drug Delivery Devices Market, By Country, 2022-2031 (Usd Million)
Table 51 Asia-pacific Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 52 Asia-pacific Oral Drug Delivery In Drug Delivery Devices Market, By Form, 2022-2031 (Usd Million)
Table 53 Asia-pacific Solid Oral Drugs In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 54 Asia-pacific Liquid Oral Drugs In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 55 Asia-pacific Semi Solid Oral Drugs In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 56 Asia-pacific Injectable Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 57 Asia-pacific Injectable Drug Delivery Formulations In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 58 Asia-pacific Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 59 Asia-pacific Conventional Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Material, 2022-2031 (Usd Million)
Table 60 Asia-pacific Conventional Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 61 Asia-pacific Conventional Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Usability, 2022-2031 (Usd Million)
Table 62 Asia-pacific Self Injection Drug Delivery Devices In Drug Delivery Devices Market, By Usability, 2022-2031 (Usd Million)
Table 63 Asia-pacific Topical Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 64 Asia-pacific Transdermal Drug Delivery Formulations In Drug Delivery Devices Market, By Form, 2022-2031 (Usd Million)
Table 65 Asia-pacific Semi-solid Topical Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 66 Asia-pacific Liquid Topical Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 67 Asia-pacific Solid Topical Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 68 Asia-pacific Ophthalmic Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 69 Asia-pacific Occular Drug Delivery Formulations In Drug Delivery Devices Market, By Form, 2022-2031 (Usd Million)
Table 70 Asia-pacific Liquid Occular Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 71 Asia-pacific Semi-solid Occular Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 72 Asia-pacific Nasal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 73 Asia-pacific Pulmonary Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 74 Asia-pacific Nebulizers In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 75 Asia-pacific Transmucosal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 76 Asia-pacific Oral Transmucosal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 77 Asia-pacific Other Transmucosal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 78 Asia-pacific Implantable Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 79 Asia-pacific Drug Delivery Devices Market, By End User, 2022-2031 (Usd Million)
Table 80 Asia-pacific Drug Delivery Devices Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 81 Japan Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 82 Japan Oral Drug Delivery In Drug Delivery Devices Market, By Form, 2022-2031 (Usd Million)
Table 83 Japan Solid Oral Drugs In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 84 Japan Liquid Oral Drugs In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 85 Japan Semi Solid Oral Drugs In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 86 Japan Injectable Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 87 Japan Injectable Drug Delivery Formulations In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 88 Japan Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 89 Japan Conventional Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Material, 2022-2031 (Usd Million)
Table 90 Japan Conventional Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 91 Japan Conventional Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Usability, 2022-2031 (Usd Million)
Table 92 Japan Self Injection Drug Delivery Devices In Drug Delivery Devices Market, By Usability, 2022-2031 (Usd Million)
Table 93 Japan Topical Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 94 Japan Transdermal Drug Delivery Formulations In Drug Delivery Devices Market, By Form, 2022-2031 (Usd Million)
Table 95 Japan Semi-solid Topical Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 96 Japan Liquid Topical Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 97 Japan Solid Topical Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 98 Japan Ophthalmic Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 99 Japan Occular Drug Delivery Formulations In Drug Delivery Devices Market, By Form, 2022-2031 (Usd Million)
Table 100 Japan Liquid Occular Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 101 Japan Semi-solid Occular Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 102 Japan Nasal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 103 Japan Pulmonary Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 104 Japan Nebulizers In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 105 Japan Transmucosal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 106 Japan Oral Transmucosal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 107 Japan Other Transmucosal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 108 Japan Implantable Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 109 Japan Drug Delivery Devices Market, By End User, 2022-2031 (Usd Million)
Table 110 Japan Drug Delivery Devices Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 111 China Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 112 China Oral Drug Delivery In Drug Delivery Devices Market, By Form, 2022-2031 (Usd Million)
Table 113 China Solid Oral Drugs In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 114 China Liquid Oral Drugs In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 115 China Semi Solid Oral Drugs In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 116 China Injectable Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 117 China Injectable Drug Delivery Formulations In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 118 China Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 119 China Conventional Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Material, 2022-2031 (Usd Million)
Table 120 China Conventional Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 121 China Conventional Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Usability, 2022-2031 (Usd Million)
Table 122 China Self Injection Drug Delivery Devices In Drug Delivery Devices Market, By Usability, 2022-2031 (Usd Million)
Table 123 China Topical Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 124 China Transdermal Drug Delivery Formulations In Drug Delivery Devices Market, By Form, 2022-2031 (Usd Million)
Table 125 China Semi-solid Topical Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 126 China Liquid Topical Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 127 China Solid Topical Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 128 China Ophthalmic Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 129 China Occular Drug Delivery Formulations In Drug Delivery Devices Market, By Form, 2022-2031 (Usd Million)
Table 130 China Liquid Occular Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 131 China Semi-solid Occular Drug Delivery Formulations In Drug Delivery Devices Market, By Type, 2022-2031 (Usd Million)
Table 132 China Nasal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 133 China Pulmonary Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 134 China Nebulizers In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 135 China Transmucosal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 136 China Oral Transmucosal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 137 China Other Transmucosal Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 138 China Implantable Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 139 China Drug Delivery Devices Market, By End User, 2022-2031 (Usd Million)
Table 140 China Drug Delivery Devices Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 141 India Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 142 India Oral Drug Delivery In Drug Delivery Devices Market, By Form, 2022-2031 (Usd Million)
Table 143 India Solid Oral Drugs In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 144 India Liquid Oral Drugs In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 145 India Semi Solid Oral Drugs In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 146 India Injectable Drug Delivery In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 147 India Injectable Drug Delivery Formulations In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 148 India Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Product Type, 2022-2031 (Usd Million)
Table 149 India Conventional Injectable Drug Delivery Devices In Drug Delivery Devices Market, By Material, 2022-2031 (Usd Million)
Figure 1 Asia-pacific Drug Delivery Devices Market: Segmentation
Figure 2 Asia-pacific Drug Delivery Devices Market: Data Triangulation
Figure 3 Asia-pacific Drug Delivery Devices Market: Droc Analysis
Figure 4 Asia-pacific Drug Delivery Devices Market: Asia-pacific Vs Regional Market Analysis
Figure 5 Asia-pacific Drug Delivery Devices Market: Company Research Analysis
Figure 6 Asia-pacific Drug Delivery Devices Market: Interview Demographics
Figure 7 Asia-pacific Drug Delivery Devices Market: Market End User Coverage Grid
Figure 8 Asia-pacific Drug Delivery Devices Market: Dbmr Market Position Grid
Figure 9 Asia-pacific Drug Delivery Devices Market: Vendor Share Analysis
Figure 10 Asia-pacific Drug Delivery Devices Market: Segmentation
Figure 11 Executive Summary
Figure 12 Eight Segments Comprise The Asia-pacific Drug Delivery Devices Market, By Product Type
Figure 13 Strategic Decisions
Figure 14 Rising Prevalence Of Chronic Disease And Non-chronic Disease Are Driving The Growth Of The Asia-pacific Drug Delivery Devices Market From 2024 To 2031
Figure 15 The Oral Drug Delivery Segment Is Expected To Account For The Largest Share Of The Asia-pacific Drug Delivery Devices Market In 2024 And 2031
Figure 16 Drivers, Restraints, Opportunities And Challenges Of Asia-pacific Drug Delivery Devices Market
Figure 17 Asia-pacific Drug Delivery Devices Market: By Product Type, 2023
Figure 18 Asia-pacific Drug Delivery Devices Market: By Product Type, 2023-2031 (Usd Million)
Figure 19 Asia-pacific Drug Delivery Devices Market: By Product Type, Cagr (2024-2031)
Figure 20 Asia-pacific Drug Delivery Devices Market: By Product Type, Lifeline Curve
Figure 21 Asia-pacific Drug Delivery Market: By End User, 2023
Figure 22 Asia-pacific Drug Delivery Devices Market: By End User, 2024-2031 (Usd Million)
Figure 23 Asia-pacific Drug Delivery Devices Market: End User, Cagr (2024-2031)
Figure 24 Asia-pacific Drug Delivery Devices Market: End User, Lifeline Curve
Figure 25 Asia-pacific Drug Delivery Devices Market: By Distribution Channel, 2023
Figure 26 Asia-pacific Drug Delivery Devices Market: By Distribution Channel, 2024-2031 (Usd Million)
Figure 27 Asia-pacific Drug Delivery Devices Market: By Distribution Channel, Cagr (2024-2031)
Figure 28 Asia-pacific Drug Delivery Devices Market: By Distribution Channel, Lifeline Curve
Figure 29 Asia-pacific Drug Delivery Devices Market: Snapshot (2023)
Figure 30 Asia-pacific Drug Delivery Devices Market: Company Share 2023 (%)